TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07763197: Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)

Sponsor: Natera, Inc. · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 400 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT07763197 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07763197 Rescue Dossier →